Satyam Ophthalmics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 23 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.16 M
- Revenue Growth 18.67%
- Profit Growth 97.17%
- Ebitda -13.83%
- Net Worth 15.88%
- Total Assets 3.23%
About Satyam Ophthalmics
Satyam Ophthalmics Private Limited (SOPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 August 2001 and has a history of 23 years and five months. Its registered office is in Agra, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹8.16 M.
Sushil Srivastava and Nilima Srivastava serve as directors at the Company.
Company Details
-
Location
Agra, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U52311UP2001PTC026191
-
Company No.
026191
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Aug 2001
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
What products or services does Satyam Ophthalmics Private Limited offer?
Satyam Ophthalmics Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Anti Infective Agent, Ophthalmic Drops, Latanoprost Ophthalmic Eye Drop, Eye Care Medicines, Lutein Capsules, Eye Drops, Herbal Eye Drops, Common Disease Medicines.
Who are the key members and board of directors at Satyam Ophthalmics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nilima Srivastava
|
Director | 05-Mar-2019 | Current |
|
Sushil Srivastava
|
Director | 22-Aug-2001 | Current |
Financial Performance of Satyam Ophthalmics.
Satyam Ophthalmics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 18.67% increase. The company also saw a substantial improvement in profitability, with a 97.17% increase in profit. The company's net worth Soared by an impressive increase of 15.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Satyam Ophthalmics?
In 2020, Satyam Ophthalmics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹8.16 M
₹0
Charges Breakdown by Lending Institutions
- Syndicate Bank : 0.59 Cr
- Hdfc Bank Limited : 0.23 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Nov 2023 | Hdfc Bank Limited | ₹1.51 M | Open |
| 17 Nov 2021 | Hdfc Bank Limited | ₹0.81 M | Open |
| 16 Jun 2016 | Syndicate Bank | ₹0.85 M | Open |
| 24 Dec 2014 | Syndicate Bank | ₹5.00 M | Open |
How Many Employees Work at Satyam Ophthalmics?
Unlock and access historical data on people associated with Satyam Ophthalmics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Satyam Ophthalmics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Satyam Ophthalmics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
